Duan, Wu <br/><br/>
Mesenchymal stem cells in combination with low-dose rapamycin significantly prolong islet allograft survival through induction of regulatory T cells.  [electronic resource] 

 -  Biochemical and biophysical research communications  11 2018 
 - 619-625 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1090-2104 
<br/><br/><label>Standard No.: </label>10.1016/j.bbrc.2018.10.070  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allografts--drug effects<br/>Animals<br/>Cell Differentiation--drug effects<br/>Combined Modality Therapy<br/>Dose-Response Relationship, Drug<br/>Graft Survival--drug effects<br/>Inflammation--pathology<br/>Islets of Langerhans Transplantation<br/>Kidney--drug effects<br/>Lymph Nodes--drug effects<br/>Mesenchymal Stem Cell Transplantation<br/>Mesenchymal Stem Cells--cytology<br/>Mesentery--drug effects<br/>Mice, Inbred C57BL<br/>Sirolimus--pharmacology<br/>Spleen--drug effects<br/>T-Lymphocytes, Regulatory--drug effects